+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AUROPHARMA

Aurobindo Pharma Share Price

 

 

Aurobindo Pharma live price: ₹1497.8. It opened at ₹1,454 vs previous close ₹1,444; intraday high/low: ₹1,503/₹1,446. The 50 & 200 DMA stand at ₹1,421.45/₹1,289.05.

Aurobindo Pharma Performance

  • Today's Low
  • ₹1,446
  • Today's High
  • ₹1,503
  • 52 Week Low
  • ₹1,016
  • 52 Week High
  • ₹1,550
  • Open Price₹1,454
  • Previous Close₹1,444
  • Volume2,506,592
  • 50 DMA₹1,421.45
  • 100 DMA₹1,359.60
  • 200 DMA₹1,289.05

Aurobindo Pharma Chart

Investment Returns

  • Over 1 Month -0.18%
  • Over 3 Month + 18.03%
  • Over 6 Month + 23.86%
  • Over 1 Year + 35.51%

Smart Investing Starts Here Start SIP with Aurobindo Pharma for Steady Growth!

Invest Now

Aurobindo Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.3
  • PEG Ratio
  • 3.3
  • Market Cap Cr
  • 86,993
  • P/B Ratio
  • 2.3
  • Average True Range
  • 37.9
  • EPS
  • 61.09
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 2.43
  • RSI
  • 59.92
  • MFI
  • 59.26

Latest Stock News Updates

Aurobindo Pharma stock jumps 2% after US FTC approves Lannett acquisition

Aurobindo Pharma received necessary approval from the US Federal Trade Commission (FTC) for the acquisition of the Lannett business.

Aurobindo Pharma sets up TheraNym, a dedicated biologics contract manufacturing body

MSD is the anchor customer for the new contract manufacturing organisation

Aurobindo Pharma to expand manufacture of generic formulations in France

Agile Pharma BV, a wholly-owned step-down arm of Aurobindo, has incorporated a new subsidiary in France, Arrow Pharma Production SAS, for this

Aurobindo Pharma Financials

Aurobindo Pharma Technicals

EMA & SMA

Current Price
₹1,497.80
+ 54.1 (3.75%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,449.60
  • 50 Day
  • ₹1,421.40
  • 100 Day
  • ₹1,359.60
  • 200 Day
  • ₹1,289.00

Resistance and Support

1482.43 Pivot Speed
  • R3 1,575.17
  • R2 1,539.13
  • R1 1,518.47
  • S1 1,461.77
  • S2 1,425.73
  • S3 1,405.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aurobindo Pharma Ltd., is a global pharmaceutical company specializing in generic and specialty pharmaceuticals. With 25 global facilities, it operates across key therapeutic areas, including antibiotics, cardiovascular, and anti-diabetics.

Aurobindo Pharma has an operating revenue of Rs. 33,653.08 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 15% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 16% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 62 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aurobindo Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results
2026-04-06 Buy Back of Shares
2026-02-09 Quarterly Results
2025-11-05 Quarterly Results
2025-08-04 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-08-08 INTERIM Rs.4.00 per share(400%)Interim Dividend
2024-02-20 INTERIM Rs.1.50 per share(150%)Second Interim Dividend
2023-11-20 INTERIM Rs.3.00 per share(300%)First Interim Dividend
2023-02-17 INTERIM Rs.3.00 per share(300%)Interim Dividend
2022-06-07 INTERIM Rs.4.50 per share (450%) Fourth Interim Dividend
View Aurobindo Pharma Dividend History Arrow

Aurobindo Pharma F&O

Aurobindo Pharma Shareholding Pattern

51.82%
17.79%
5%
15.24%
0%
5.74%
4.41%

Aurobindo Pharma FAQs

Aurobindo Pharma share price is ₹1,497 As on 20 June, 2026 | 04:58

The Market Cap of Aurobindo Pharma is ₹86992.5 Cr As on 20 June, 2026 | 04:58

The P/E ratio of Aurobindo Pharma is 23.3 As on 20 June, 2026 | 04:58

The PB ratio of Aurobindo Pharma is 2.3 As on 20 June, 2026 | 04:58

Aurobindo Pharma has an operating revenue of Rs.24,010.31 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 30% is great. Many brokers and analysts have recommended 'Buy' on the stock.

Aurobindo Pharma Ltd. has declared 40 dividends since May 10, 2000.

The stock price CAGR of Aurobindo Pharma for 10 Years is 30%, 5 Years is 0%, 3 Years is -3%, 1 Year is -25%.

Aurobindo Pharma has an ROE of 24% which is exceptional.

Aurobindo Pharma has a reasonable debt to equity of 1%, which signals a healthy balance sheet.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23